The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA

被引:4
作者
Divino, Victoria [1 ]
Schranz, Jennifer [2 ]
Early, Maureen [2 ]
Shah, Hemal [3 ]
Jiang, Miao [1 ]
DeKoven, Mitch [1 ]
机构
[1] IQVIA, Falls Church, VA 22042 USA
[2] Nabriva Therapeut US Inc, King Of Prussia, PA 19406 USA
[3] Value Matters LLC, Ridgefield, CT 06877 USA
关键词
administrative claims; community-acquired pneumonia; cost of illness; healthcare costs; pneumonia; retrospective studies; UNITED-STATES; COSTS; CARE; AGE; HOSPITALIZATIONS;
D O I
10.2217/cer-2019-0151
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aim: To assess the annual economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting. Patients & methods: Patients with an outpatient diagnosis of CAP between January 2012 and December 2016 were identified from the IQVIA (Danbury, CT & Durham, NC, USA) Real-World Data Adjudicated Claims - US Database. All-cause and CAP-related healthcare resource utilization and costs were assessed over the 1-year follow-up. Generalized linear model examined adjusted total cost. Results: Among 256,916 patients with outpatient CAP, a tenth (10.6%) had >= 1 hospitalization and, of these, 18.7% had >= 1 CAP-related hospitalization. The mean total cost per patient was US$14,372; 10.9% was CAP-related and 26.1% was due to inpatient care. The adjusted mean total all-cause cost was US$13,788. Conclusion: Patients with outpatient CAP incurred a substantial annual economic burden.
引用
收藏
页码:127 / 140
页数:14
相关论文
共 31 条
[1]  
Agency for Healthcare Research and Quality R MD., 2018, COMM ACQ PNEUM CLIN
[2]  
[Anonymous], 2016, FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme
[3]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[4]  
Bonafede MM, 2012, AM J MANAG CARE, V18, P380
[5]   Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease [J].
Bornheimer, Rebecca ;
Shea, Kimberly M. ;
Sato, Reiko ;
Weycker, Derek ;
Pelton, Stephen I. .
PLOS ONE, 2017, 12 (10)
[6]  
Broulette J, 2013, AM HEALTH DRUG BENEF, V6, P494
[7]   Trends in US hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011 [J].
Chang, D. H. ;
Bednarczyk, Robert A. ;
Becker, Edmund R. ;
Hockenberry, Jason M. ;
Weiss, Paul S. ;
Orenstein, Walter A. ;
Omer, Saad B. .
VACCINE, 2016, 34 (04) :486-494
[8]   Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up [J].
Eurich, Dean T. ;
Marrie, Thomas J. ;
Minhas-Sandhu, Jasjeet K. ;
Majumdar, Sumit R. .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[9]   Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia [J].
Fine, MJ ;
Pratt, HM ;
Obrosky, DS ;
Lave, JR ;
McIntosh, LJ ;
Singer, DE ;
Coley, CM ;
Kapoor, WN .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (05) :378-385
[10]   Burden of Pneumonia-Associated Hospitalizations United States, 2001-2014 [J].
Hayes, Brandon H. ;
Haberling, Dana L. ;
Kennedy, Jordan L. ;
Varma, Jay K. ;
Fry, Alicia M. ;
Vora, Neil M. .
CHEST, 2018, 153 (02) :427-437